A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 922
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LVADs
Long Form : left ventricular assist devices
No. Year Title Co-occurring Abbreviation
2020 A Physiological Control System for an Implantable Heart Pump That Accommodates for Interpatient and Intrapatient Variations. LVEDP, MFAC, SAE
2020 Abdominal Surgery in Patients with a Ventricular Assist Device: A Single Center Experience in Israel. ---
2020 Adults Living With a Retro-auricular Left Ventricular Assist Device as Destination Therapy: An Interpretive Description. ---
2020 Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support. DCM, ICM, LV, NF, RAS
2020 Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices. ---
2020 Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support. AI
2020 Association between recipient blood type and heart transplantation outcomes in the United States. CI, HT
2020 Association of cigarette smoking and adverse events in left ventricular assist device patients. AEs
2020 Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. BTC, BTT, DT, HM3, HMII
10  2020 Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. AMI, IABPs, MCS, PCI
11  2020 Atrial arrhythmias in patients with left ventricular assist devices. HFrEF
12  2020 Awake and aware with ongoing ventricular fibrillation during LVAD treatment: is it possible? CHF, VF
13  2020 Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices. HR, NHB
14  2020 Biomechanical effects of the working modes of LVADs on the aortic valve: A primary numerical study. ---
15  2020 Bionic women and men - Part 1: Cardiovascular lessons from heart failure patients implanted with left ventricular assist devices. LVAD
16  2020 Bionic women and men - Part 2: Arterial stiffness in heart failure patients implanted with left ventricular assist devices. CF
17  2020 Bionic women and men - Part 4: Cardiovascular, cerebrovascular and exercise responses among patients supported with left ventricular assist devices. ---
18  2020 Bridging the Communication Gap: A Quality Improvement Project of a Ventricular Assist Device Program. VAD
19  2020 Cardiac Contractility Monitoring: an Important Therapy in the Treatment of Advanced Heart Failure. CCM, CRT, HFrEF, OMT
20  2020 Cardiac Rehab for Functional Improvement. AHA/ACC, CAD, CR, HFrEF, MI, PAD, TAVR
21  2020 Cataract surgery in patients with left ventricular assist devices. ---
22  2020 Cerebral blood flow responses to exercise are enhanced in left ventricular assist device patients after an exercise rehabilitation program. ICA
23  2020 Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. aHR, QOL, TR, TVPs
24  2020 Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? CABG, CABG
25  2020 Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis. ---
26  2020 Comparison of Trends, Mortality, and Readmissions After Insertion of Left Ventricular Assist Devices in Patients <65 Years Vs ≥65 Years. HF
27  2020 Considerations for HeartFailure Care During the COVID-19 Pandemic. HF
28  2020 Critical Care Management of the Acute Postimplant LVAD Patient. ---
29  2020 Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management. ANOVA, LVAS, rpm, vWF
30  2020 Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. INTERMACS
31  2020 Depression and Anxiety Moderate the Relationship Between Body Image and Personal Well-being Among Patients With an Implanted Left Ventricular Assist Device. ---
32  2020 Detecting Suspected Pump Thrombosis in Left Ventricular Assist Devices via Acoustic Analysis. ---
33  2020 Diagnosis and Treatment Strategies of Outflow Graft Obstruction in the Fully Magnetically Levitated Continuous-Flow centrifugal Left Ventricular Assist Device: A Multicenter Case Series. ---
34  2020 Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS. ---
35  2020 Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. HM3, HRAEs
36  2020 Effect of Pulmonary Hypertension on Transplant Outcomes in Patients With Ventricular Assist Devices. aHRs, PVR
37  2020 Effects of continuous-flow left ventricular assist devices on cerebral hemodynamics. CA, EDV, MCA, PI, PSV, RI
38  2020 Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices. ---
39  2020 Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators. EMI, ICDs, S-ICD
40  2020 Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices. EMI, HM3, HMII, ICDs, PMs
41  2020 Ethical Challenges in Care of Patients on Mechanical Circulatory Support at End-of-Life. EOL, MCS
42  2020 Evaluating medical device adverse event signals using a likelihood ratio test method. AE, BCPNN, LRT, MDR, PRRs
43  2020 Examining Hearts Containing Left Ventricular Assist Devices at Necropsy. LV
44  2020 Exploring illness denial of LVAD patients in cardiac rehabilitation and their caregivers: A preliminary study. ---
45  2020 Food and Drug Administration Malfunction Recalls of Left Ventricular Assist Devices. FDA
46  2020 Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients' response and cardiorespiratory simulations. ---
47  2020 Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices. CO
48  2020 Impact of chronic kidney disease on in-hospital outcomes following left ventricular assist device placement: A national perspective. CKD, LV
49  2020 Impact of Left Ventricular Assist Device Exchange on Outcomes After HeartTransplantation. ---
50  2020 Impact of Shared Care in RemoteAreasfor Patients With LeftVentricular Assist Devices. IC
51  2020 Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique. HM3, SS, TS
52  2020 In Full Flow: Left Ventricular Assist Device Infections in the Modern Era. MCS
53  2020 In Vitro Benchmarking Study of Ventricular Assist Devices in Current Clinical Use. LMPs, vWF
54  2020 In vitro evaluation of multi-objective physiological control of the centrifugal blood pump. FwC, FzC, HF, HR, MAP
55  2020 In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions. HVAD, pediatric LVADs, RVADs
56  2020 In-hospital Outcomes of Left Ventricular Assist Devices (LVAD) Patients Undergoing Noncardiac Surgery. LOS, LVAD, NCS
57  2020 Independent risk factors for ICU mortality after left ventricular assist device implantation. ICU
58  2020 Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices. HM3, INR, LDH, PAS, TGT
59  2020 Laparoscopic gastrectomy for heart failure patients with left ventricular assist devices. ---
60  2020 Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation. ---
61  2020 Management of Aortic Insufficiency Using Transcatheter Aortic Valve Replacement in Patients with Left Ventricular Assist Device Support. AI, TAVR
62  2020 Management of ventricular arrhythmias in patients with LVAD. ---
63  2020 Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry. BTT, CI, HR, UNOS
64  2020 Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device. ESWL
65  2020 Mechanical Circulatory Support in Women. CS, HF, MCS
66  2020 Medical Management of Left Ventricular Assist Device Patients: A Practical Guide for the Nonexpert Clinician. ---
67  2020 Miniaturized Test Loop for the Assessment of Blood Damage by Continuous-Flow Left-Ventricular Assist Devices. ASTM, PFHb, vWF
68  2020 Minimally invasive left ventricular assist device implantation: optimizing device design for this approach. HF, MCS
69  2020 Neurohormonal Blockade and Clinical Outcomes in Patients With Heart Failure Supported by Left Ventricular Assist Devices. INTERMACS, NHB
70  2020 Neurohormonal Blockade During Left Ventricular Assist Device Support. ACEI, ARB, BB, HF, NHB
71  2020 Neutrophil to Lymphocyte Ratio Is Related to Thrombotic Complications and Survival in Continuous Flow Left Ventricular Assist Devices. CI, HR, IQR, NLR
72  2020 Nontuberculous mycobacterial infections in left ventricular assist device patients. NTM
73  2020 Omega-3 and hemocompatibility-related adverse events. HRAEs
74  2020 Out of hospital management of LVAD patients during COVID-19 outbreak. COVID-19
75  2020 Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: AnInteragency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. INTERMACS
76  2020 Outcomes of left ventricular assist device implantation in hypercoagulable patients. ---
77  2020 Over 870 days of successful antibiotic suppression therapy for VRE-infected left ventricular assist device. VRE
78  2020 Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction. HF
79  2020 Percutaneous treatment of left ventricular assist device outflow graft obstruction. ---
80  2020 Preoperative Right Heart Dysfunction and Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices. AVMs, CI, GIB, HR, RV, TV
81  2020 Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage HeartFailure. HF
82  2020 Pulsatility in ventricular assistance devices: A translational review focused on applied haemodynamics. ---
83  2020 Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis. ---
84  2020 Reducing ECG Artifact From Left Ventricular Assist Device Electromagnetic Interference. ---
85  2020 Risk of pump thrombosis and stroke in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding. GI
86  2020 Sex-Based Heart Transplant Outcomes After Bridging With Centrifugal Left Ventricular Assist Devices. OHT
87  2020 Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ---
88  2020 Statistics of heart failure and mechanical circulatory support in 2020. BTT, ECMO, MCS, pEF, rEF, RVADs
89  2020 Survival After Heart Transplantation in Patients Bridged With Mechanical Circulatory Support. ECMO, TCS-VAD, UNOS
90  2020 Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. HMII, rpm
91  2020 Temporal trends and outcomes of patients waiting on left ventricular assist devices and inotropes for heart transplantation. RVAD, SHR, UNOS
92  2020 The influence of left ventricular assist device inflow cannula position on thrombosis risk. CFD, IC, LV, WSS
93  2020 The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications. CF-FML, CF-HL, DT
94  2020 The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis. CI
95  2020 Thermal evaluation of a hermetic transcutaneous energy transfer system to power mechanical circulatory support devices in destination therapy. DT, TET
96  2020 Transition from Conventional Technique to Less Invasive Approach in Left Ventricular Assist Device Implantations. ---
97  2020 Utility and safety of balloon-assisted enteroscopy in patients with left ventricular assist devices: a retrospective multicenter study. BAE, DBEs, SBEs
98  2019 A network meta-analysis of randomized trials and observational studies on left ventricular assist devices in adult patients with end-stage heart failure. CIs
99  2019 A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility. CD, ELISA
100  2019 A Systematic Review of Cost-Effectiveness Analyses of Left Ventricular Assist Devices: Issues and Challenges. BTT, DT, HF, HT